Side effects of synthetic salmon calcitonin given by intranasal spray compared with intramuscular injection
- PMID: 2410171
Item in Clipboard
Side effects of synthetic salmon calcitonin given by intranasal spray compared with intramuscular injection
Clin Exp Rheumatol.
1985 Apr-Jun.
Abstract
Side effects are the most frequent reason for discontinuing treatment with Calcitonin. Having been assessed in a previous report that the intranasal administration of Synthetic Salmon Calcitonin (SSCT) is as effective as its intramuscular administration, the aim of this work was to investigate the side-effects of intranasal administration of SSCT in patients who are known to show intolerance after intramuscular administration of the drug. The results show that intranasal administration of SSCT does not give rise to side-effects even in patients known to be intolerant to SSCT by the intramuscular route.
Similar articles
-
Assessment of the biological effectiveness of nasal synthetic salmon calcitonin (SSCT) by comparison with intramuscular (i.m.) or placebo injection in normal subjects.Bone Miner. 1987 Apr;2(2):133-40. Bone Miner. 1987. PMID: 3504725 Clinical Trial.
-
Treatment of Paget's disease of bone with salmon calcitonin nasal spray.J Am Geriatr Soc. 1988 Nov;36(11):1010-4. J Am Geriatr Soc. 1988. PMID: 3171038
-
Comparison of the acute effect of the intranasal and intramuscular administration of salmon calcitonin in Paget's disease.Calcif Tissue Int. 1987 Dec;41(6):313-5. doi: 10.1007/BF02556668. Calcif Tissue Int. 1987. PMID: 3124939
-
Salmon calcitonin: state of the art in prevention of postmenopausal bone loss?Acta Belg Med Phys. 1989 Apr-Jun;12(2):41-6. Acta Belg Med Phys. 1989. PMID: 2690544 Review. No abstract available.
-
Calcitonin in reflex sympathetic dystrophy syndrome and other painful conditions.Bone. 2002 May;30(5 Suppl):84S-86S. doi: 10.1016/s8756-3282(02)00702-0. Bone. 2002. PMID: 12008165 Review.
Cited by
-
Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis.Front Pharmacol. 2022 Jun 14;13:938447. doi: 10.3389/fphar.2022.938447. eCollection 2022. Front Pharmacol. 2022. PMID: 35774616 Free PMC article. Review.
-
Calcitonin: A useful old friend.J Musculoskelet Neuronal Interact. 2020 Dec 1;20(4):600-609. J Musculoskelet Neuronal Interact. 2020. PMID: 33265089 Free PMC article. Review.
-
Insights and implications of sexual dimorphism in osteoporosis.Bone Res. 2024 Feb 18;12(1):8. doi: 10.1038/s41413-023-00306-4. Bone Res. 2024. PMID: 38368422 Free PMC article. Review.
-
Buccal transmucosal delivery of calcitonin in rabbits using thin-film composites.Pharm Res. 2002 Dec;19(12):1901-6. doi: 10.1023/a:1021462012442. Pharm Res. 2002. PMID: 12523672
-
Bone loss during gonadotropin releasing hormone agonist treatment and use of nasal calcitonin.Osteoporos Int. 1995 May;5(3):185-90. doi: 10.1007/BF02106098. Osteoporos Int. 1995. PMID: 7655179 Clinical Trial.